These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9650845)
1. Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. Haapalinna A; Sirviö J; Lammintausta R Eur J Pharmacol; 1998 Apr; 347(1):29-40. PubMed ID: 9650845 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306 [TBL] [Abstract][Full Text] [Related]
3. The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. Haapalinna A; Sirviö J; MacDonald E; Virtanen R; Heinonen E Eur J Pharmacol; 2000 Jan; 387(2):141-50. PubMed ID: 10650154 [TBL] [Abstract][Full Text] [Related]
4. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. Chopin P; Colpaert FC; Marien M J Pharmacol Exp Ther; 2002 Apr; 301(1):187-96. PubMed ID: 11907173 [TBL] [Abstract][Full Text] [Related]
5. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related]
7. Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats. Puurunen K; Sirviö J; Koistinaho J; Miettinen R; Haapalinna A; Riekkinen P; Sivenius J Stroke; 1997 Mar; 28(3):623-31. PubMed ID: 9056622 [TBL] [Abstract][Full Text] [Related]
8. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
9. Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy. Nissinen J; Andrade P; Natunen T; Hiltunen M; Malm T; Kanninen K; Soares JI; Shatillo O; Sallinen J; Ndode-Ekane XE; Pitkänen A Epilepsy Res; 2017 Oct; 136():18-34. PubMed ID: 28753497 [TBL] [Abstract][Full Text] [Related]
10. The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats. Sirviö J; Riekkinen P; MacDonald E; Airaksinen M; Lammintausta R; Riekkinen PJ J Neural Transm Park Dis Dement Sect; 1992; 4(2):99-106. PubMed ID: 1349212 [TBL] [Abstract][Full Text] [Related]
11. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters. Kauppila T; Jyväsjärvi E; Hämäläinen MM; Pertovaara A Pharmacol Biochem Behav; 1998 Feb; 59(2):477-85. PubMed ID: 9476998 [TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Jolkkonen J; Puurunen K; Rantakömi S; Härkönen A; Haapalinna A; Sivenius J Eur J Pharmacol; 2000 Jul; 400(2-3):211-9. PubMed ID: 10988336 [TBL] [Abstract][Full Text] [Related]
13. Atipamezole, an alpha 2 antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects. Riekkinen P; Sirviö J; Riekkinen M; Lammintausta R; Riekkinen P Pharmacol Biochem Behav; 1992 Mar; 41(3):611-4. PubMed ID: 1350102 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. Pertovaara A; Haapalinna A; Sirviö J; Virtanen R CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294 [TBL] [Abstract][Full Text] [Related]
15. Effects of a selective alpha 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo. Laitinen KS; Tuomisto L; MacDonald E Eur J Pharmacol; 1995 Oct; 285(3):255-60. PubMed ID: 8575511 [TBL] [Abstract][Full Text] [Related]
16. Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system. Stornetta RL; Grubb MC; Guyenet PG Brain Res; 1997 Aug; 764(1-2):81-92. PubMed ID: 9295196 [TBL] [Abstract][Full Text] [Related]
17. Noradrenergic terminals are the primary source of α Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147 [TBL] [Abstract][Full Text] [Related]
18. Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats. Niittykoski M; Lappalainen R; Jolkkonen J; Haapalinna A; Riekkinen P; Sirviö J Neurosci Biobehav Rev; 1998 Oct; 22(6):735-50. PubMed ID: 9809309 [TBL] [Abstract][Full Text] [Related]
19. Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Jäkälä P; Sirviö J; Riekkinen P; Haapalanna A; Riekkinen P Pharmacol Biochem Behav; 1992 Aug; 42(4):903-7. PubMed ID: 1355298 [TBL] [Abstract][Full Text] [Related]
20. Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Björklund M; Sirviö J; Sallinen J; Scheinin M; Kobilka BK; Riekkinen P Neuroscience; 1999; 88(4):1187-98. PubMed ID: 10336129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]